Dillard's, Inc. DDS
664.07
18.41
2.85%
as of 25 Sep
- Market cap
- $10.2B
- P/E
- 15.2×
Follow DDS
| Jul '26 | Apr '26 | Jan '26 | Oct '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.48 | 13.53 | 17.38 | 16.29 |
+8 more quarters Free account |
P/S ratio |
1.39 | 1.35 | 1.51 | 1.41 | |
P/FCF ratio |
14.03 | 11.39 | 15.26 | 11.87 | |
P/Operating CF |
(247.17) | 24.42 | 46.92 | 50.25 | |
P/B ratio |
4.33 | 4.39 | 5.57 | 4.58 | |
Price to Tangible BV |
4.33 | 4.39 | 5.57 | 4.58 | |
EV/Sales |
1.27 | 1.21 | 1.43 | 1.29 | |
EV/EBITDA |
9.15 | 9.12 | 10.76 | 9.53 | |
EV/Operating CF |
11.53 | 9.42 | 13.05 | 9.83 | |
EV/FCF |
12.75 | 10.24 | 14.41 | 10.84 | |
Quick Ratio |
1.49 | 1.14 | 1.23 | 0.95 | |
Current Ratio |
3.03 | 2.37 | 2.65 | 2.19 | |
Net Debt/EBITDA |
(4.80) | (3.31) | (2.18) | (3.78) | |
Debt/Assets |
11.35% | 12.61% | 14.88% | 12.14% | |
Debt/Equity |
0.20 | 0.26 | 0.29 | 0.26 | |
Asset Turnover |
1.78 | 1.64 | 1.87 | 1.57 | |
Operating CF/Net income |
(0.38) | 1.45 | 1.04 | 1.44 | |
Capex/Depreciation |
(0.50) | (0.39) | (0.03) | (0.64) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
28.99% | 27.95% | 23.27% | 29.54% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.11 | 0.11 | 0.07 | 0.10 | |
Graham Number |
365.17 | 350.35 | 305.11 | 329.50 | |
Earnings Yield |
7.42% | 7.39% | 5.75% | 6.14% | |
Free Cash Flow Yield |
7.13% | 8.78% | 6.55% | 8.42% | |
Revenue per Share |
97.99 | 101.72 | 127.08 | 95.50 | |
Operating CF per Share |
(2.38) | 23.31 | 13.49 | 11.94 | |
Capex per Share |
(1.42) | (1.09) | (0.09) | (1.84) | |
Free Cash Flow per Share |
(3.80) | 22.22 | 13.40 | 10.10 | |
Cash per Share |
80.72 | 90.76 | 68.54 | 85.47 | |
Shareholders Equity per Share |
135.78 | 129.70 | 113.64 | 130.98 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
135.78 | 129.70 | 113.64 | 130.98 | |
Free Cash Flow |
(59.34) | 346.94 | 209.75 | 157.73 | |
Working Capital |
1,797.51 | 1,759.74 | 1,484.49 | 1,723.58 | |
Capital Expenditures |
(22.17) | (17.04) | (1.41) | (28.73) | |
Net Current Asset Value |
1,052.11 | 934.86 | 660.52 | 916.01 | |
EV/EBIT |
11.39 | 11.46 | 13.58 | 11.86 | |
Capex to Sales |
0.01 | 0.01 | 0.00 | 0.02 | |
Net Profit Margin |
6.38% | 15.77% | 10.24% | 8.71% | |
Price to Operating Income |
12.53 | 12.75 | 14.39 | 12.98 | |
| Other line items | |||||
Average Receivables |
54.57 | 51.99 | 47.71 | 53.32 | |
Average Payables |
777.96 | 1,069.04 | 783.71 | 1,214.48 | |
Average Inventory |
1,251.51 | 1,487.91 | 1,186.57 | 1,700.14 | |
Average Assets |
3,717.17 | 4,022.39 | 3,518.04 | 4,215.56 | |
Average Common Equity |
2,019.90 | 1,941.72 | 1,787.57 | 2,004.22 |
Columns are period end dates